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Several lines of evidence indicate that schizophrenia has a strong genetic component.
But the exact nature and functional role of this genetic component in the pathophysiology
of this mental illness remains a mystery. Long non-coding RNAs (lncRNAs) are a
recently discovered family of molecules that regulate gene transcription through a variety
of means. Consequently, lncRNAs could help us bring together apparent unrelated
findings in schizophrenia; namely, genomic deficiencies on one side and neuroimaging,
as well as postmortem results on the other. In fact, the most consistent finding in
schizophrenia is decreased brain size together with enlarged ventricles. This anomaly
appears to originate from shorter and less ramified dendrites and axons. But a
decrease in neuronal arborizations cannot explain the complex pathophysiology of this
psychotic disorder; however, dynamic changes in neuronal structure present throughout
life could. It is well recognized that the structure of developing neurons is extremely
plastic. This structural plasticity was thought to stop with brain development. However,
breakthrough discoveries have shown that neuronal structure retains some degree of
plasticity throughout life. What the neuroscientific field is still trying to understand is how
these dynamic changes are regulated and lncRNAs represent promising candidates to
fill this knowledge gap. Here, we present evidence that associates specific lncRNAs
with schizophrenia. We then discuss the potential role of lncRNAs in neurostructural
dynamics. Finally, we explain how dynamic neurostructural modifications present
throughout life could, in theory, reconcile apparent unrelated findings in schizophrenia.
Keywords: neurite formation, brain development, dendrites, axons, dendritic spines, brain structure, epigenetics,
gene
Introduction
Several lines of evidence indicate that schizophrenia has a strong genetic component, including;
heritability estimates of 80–85% (Cardno et al., 1999), high rates of monozygotic concordance
(Cardno et al., 1999; Cardno andGottesman, 2000) and its association with several discrete genomic
regions (Sullivan et al., 2012; Ripke et al., 2013). But the role of this genetics in the pathophysiology
of schizophrenia remains a mystery. Recently discovered regulatory mechanisms of gene
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transcription could help us bring together apparent unrelated
findings in schizophrenia namely genomic deficiencies on one
side and neuroimaging findings, as well as postmortem results on
the other. Long non-coding RNAs (lncRNAs) are an important
part of these new regulatory mechanisms as they affect gene
transcription through a variety of means such as acting as Natural
antisense transcripts (NATs; Magistri et al., 2012) or via dosage
compensation of the XX or XY chromosomes (Moran et al.,
2012). LncRNAs also regulate gene expression by a mechanism
known as genomic imprinting and through its interaction with
paraspeckles (Mattick et al., 2009; Wang and Chang, 2011;
Moran et al., 2012). Potential lncRNA implications throughout
cell biology are enormous and neurons are not excluded.
Numerous lncRNAs are expressed in the central nervous
system (CNS) where they participate in essential processes for
normal brain development (Fenoglio et al., 2013). This is of
particular importance as schizophrenia is generally considered a
neurodevelopmental disorder (Marenco and Weinberger, 2000;
Rapoport et al., 2005). It is therefore not surprising that
there is emerging evidence of lncRNAs association with this
mental illness given these molecules play crucial roles in brain
development. What remains to be determined is confirmatory
evidence of these findings and more importantly, which cellular
process they regulate. To explore such a complex question, we
have to rely on commonalities in findings from patients with
schizophrenia.
Among the most consistent findings in schizophrenia are
ventricular enlargement and decreased brain volume (Van
Horn and McManus, 1992; Wright et al., 2000; Woods
et al., 2005). How these findings come about remains
under intense research, however; neuropathological studies
have shown that neurons from patients with schizophrenia
present shorter and less ramified dendrites and axons (Van
Horn and McManus, 1992; Wright et al., 2000; Woods
et al., 2005; Bellon et al., 2011). Even neuronal-like cells
differentiated from skin fibroblasts exhibit shorter extensions
(Brennand et al., 2011), while glial cells also from psychotic
individuals exhibit abnormal arborizations (Rajkowska et al.,
2002). A discreet shrinkage of dendrites and axons present
throughout the brain could lead to smaller brains and enlarged
ventricles, but it does not explain the complex pathophysiology
of schizophrenia. However, dynamic changes in neuronal
structure that are present throughout life could provide an
explanation.
It is well recognized that the structure of developing neurons
is extremely plastic undergoing constant extension and retraction
of neuronal arborizations (Tavosanis, 2012; Urbanska et al.,
2012). This structural plasticity was once thought to stop with
brain development. Nonetheless, breakthrough discoveries in
neurosciences have shown that the old dogma of a static neuronal
structure in adulthood is no longer applicable. Instead, it is
now known that neuronal structure remains plastic throughout
life (Holtmaat and Svoboda, 2009; Nacher et al., 2013). Adult
neurons change their shape even at baseline when they are
not being stimulated by environmental cues (Mizrahi and Katz,
2003; De Paola et al., 2006; Galimberti et al., 2006; Lee et al.,
2006; Nishiyama et al., 2007; Chow et al., 2009; Marik et al.,
2010; Chen et al., 2011). In the presence of stimuli such
as learning, these structural modifications become even more
dramatic (Holtmaat and Svoboda, 2009; Caroni et al., 2012).
Stress also causes drastic changes in neuronal shape including
dendritic atrophy in the prefrontal cortex and hippocampus,
whereas in the amygdala it promotes dendritic growth (Radley
and Morrison, 2005). The adult brain’s ability to retain a degree
of structural plasticity is evident. What the neuroscientific field
is still trying to understand is how these dynamic changes are
regulated and lncRNAs are promising candidates. Therefore, the
goals of this review are to: (1) briefly present how lncRNAs
exert their multiple regulatory mechanisms; (2) determine if
there is evidence associating lncRNAs to schizophrenia; and (3)
explore if genes regulated by lncRNAs linked to schizophrenia
impact neuronal structure. We then discuss the potential role
of lncRNAs in neurostructural dynamics and how dynamic
structural modifications occurring throughout life could, in
theory, reconcile apparent unrelated findings in schizophrenia.
Methods
A systematic review of the literature was conducted via
MEDLINE and Google Scholar using search terms such
as lncRNAs, neuronal structure, dendrite, axons, dendritic
spines, axonal boutons, structural plasticity, neuronal
differentiation and schizophrenia. The search was limited
to studies published in English. Regarding the association of
lncRNAs with schizophrenia, only studies involving patients
with schizophrenia were included; any articles associating
lncRNAs with schizophrenia through animal models were
excluded.
Long Non-Coding RNAs Mechanisms of Action
Seventy-to-seventy five percent of the eukaryotic genome
encodes transcripts that do not have an obvious potential to
encode proteins and are popularly called non-coding RNA
(ncRNA; Consortium, 2012; Pennisi, 2012). For many years,
the role of ncRNAs remained a mystery. Only recently,
significant progress has been made in understanding how
ncRNAs participate in a number of essential cellular processes.
NcRNAs are broadly classified into long and small ncRNA
depending upon the length of the transcript. Small ncRNAs
(less than 200 bp in length) include micro RNAs (miRNAs),
piwi-interacting RNAs (piRNAs), endogenous small-interfering
RNAs (siRNAs) and small nucleolar RNAs (snoRNAs), and
have all been extensively reviewed in the literature (Carthew
and Sontheimer, 2009; Ghildiyal and Zamore, 2009; Malone
and Hannon, 2009; Magistri et al., 2012). On the other hand,
lncRNAs are defined as transcripts longer than 200 bp. Similar
to messenger RNAs (mRNA) they are RNA polymerase II
transcripts that are capped, spliced and polyadenylated, yet
do not function as templates for protein synthesis (Mercer
et al., 2009; Ponting et al., 2009). LncRNA genes maintain
features common to protein-coding genes such as promoter
regions, intron-exon boundaries and alternative splicing, but lack
extended translational open reading frames (ORFs). Moreover,
they are mainly nuclear localized, less polyadenylated and more
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tissue-specific than protein-coding genes (Barry, 2014). The
number of total lncRNAs is in the range of 20,000 transcripts.
The crucial task is to determine whether all these transcripts are
functional or not. So far, over 200 lncRNAs have been studied
and many of these show evidence of functionality, at least in vitro
(Moran et al., 2012).
Intense research during the past few years has revealed that
themain function of lncRNAs is to regulate gene expression. This
regulation is executed through a variety of complex mechanisms
that include: acting as NATs, as well as via dosage compensation,
genomic imprinting and through nuclear organization (Mattick
et al., 2009; Mercer et al., 2009; Wang and Chang, 2011). In the
following sections, we will briefly review each of these regulatory
processes to highlight the importance of lncRNAs to maintain
cellular homeostasis.
NATs are a well characterized type of lncRNA which arise
from the opposite strand of protein-coding or non-protein-
coding genes (Faghihi and Wahlestedt, 2009). They can regulate
mRNA expression at the level of transcription via competition for
regulatory factors, or through physically hindering the progress
of transcription, either topologically or by being transcribed
themselves (Munroe and Zhu, 2006). It is also possible for NATs
to edit or activate cellular siRNA-related pathways that lead
to degradation of homologous transcripts ultimately eliciting
gene silencing (Kumar and Carmichael, 1998; Munroe and
Zhu, 2006). Consequently, NATs can potentially regulate any
step in RNA processing including translation, polyadenylation,
splicing, transport or even degradation (Munroe and Zhu,
2006). NATs can also bind to epigenetic enzymes and act
as scaffold to form active or repressive chromatin modifying
complexes (Magistri et al., 2012). DISC-2, Evf2 and BDNF-
AS are examples of NATs that have been associated with
several neurodegenerative, neurodevelopment and psychiatric
disorders like schizophrenia, bipolar disorder and autism
(Millar et al., 2004; Williams et al., 2009; Velmeshev et al.,
2013). NATs have also been documented for the Fragile X
Mental Retardation gene (FMR1). Although Fragile X Syndrome
(FXS) is considered a monogenetic disorder, there is evidence
that supports an alternative model in which other ncRNAs
contribute to FXS pathogenesis and the phenotypic variations
observed among patients (Ladd et al., 2007; Khalil et al.,
2008).
Dosage compensation is a hypothetical genetic regulatory
mechanism that operates to equalize the phenotypic expression
of characteristics determined by genes on the X chromosome
so that they are equally expressed in humans carrying the
XY chromosomes or the XX combination. For instance,
Xist—perhaps the best studied lncRNA—is responsible for
the initiation of X chromosome inactivation (Xi) in female
somatic cells (Augui et al., 2011; Pontier and Gribnau,
2011). Xist silences hundreds of genes on the inactive
X chromosome (Zhao et al., 2008) and this process is
essential for normal brain development (Qureshi and Mehler,
2010).
LncRNAs also regulate gene expression through a mechanism
known as genomic imprinting. The expression of imprinted
genes depends on their parental origin and the level of
differential expression of the two alleles of an imprinted
gene can vary from one imprinted gene to another (Moran
et al., 2012). Some lncRNAs can exert their function by
recruiting epigenetic factors such as PCR2 and G9a, in order
to control the imprinted expression of neighboring coding
genes (Nagano et al., 2008; Zhao et al., 2008). Other lncRNAs
such as Kcna1ot1, regulate genomic imprinting by interacting
with repressive chromatin modifying complexes that ultimately
suppress paternally inherited genes (Kanduri et al., 2006; Pandey
et al., 2008). Of note, a number of authors have proposed that
mental and neurological disorders such as schizophrenia and
autism are often influenced by deregulation of the imprinting
processes (Francks et al., 2003; Schulze et al., 2004; Schanen,
2006).
A recently discovered mechanism by which lncRNAs regulate
gene expression is through their interaction with paraspeckles.
Paraspeckles are membraneless subnuclear bodies (Mao et al.,
2011b) that participate in nuclear organization, a phenomenon
linked to genome maintenance and to the control of gene
expression (Bond and Fox, 2009). These subnuclear bodies seem
to regulate gene expression post-transcriptionally by retaining
hyper-edited mRNAs in the nucleus (Prasanth et al., 2005; Bond
and Fox, 2009; Chen and Carmichael, 2009; Clemson et al.,
2009). It is noteworthy that formation and maintenance of
paraspeckles requires the lncRNA named NEAT1 that localizes
exclusively to paraspeckles (Clemson et al., 2009; Sunwoo et al.,
2009; Mao et al., 2011a; Shevtsov and Dundr, 2011). NEAT1 has
been found to be upregulated in neurological diseases such as
Huntington’s disease (Johnson, 2012). Furthermore, analyses of
633 human spinal motor neurons in six cases of amyotrophic
lateral sclerosis (ALS) showed that NEAT1 was upregulated
during the early stage of ALS pathogenesis (Nishimoto et al.,
2013).
It is clear from the preceding short overview that lncRNAs
regulate gene expression through a number of complex genetic
mechanisms. Deregulation of these complex genetic processes
can lead to mental illnesses such as schizophrenia and therefore
lncRNAs are promising candidates to explain the strong, but still
uncharacterized, genetic component of this psychotic disorder.
In the following section, we present data connecting lncRNAs
with schizophrenia.
Long Non-Coding RNAs (lncRNAs) and
Schizophrenia
It is widely accepted that schizophrenia is a neurodevelopmental
disorder (Marenco and Weinberger, 2000; Rapoport et al.,
2005). It is also well recognized that schizophrenia is a severe
multifactorial condition with a complex genetic component;
therefore it is not surprising that previously unrecognized non-
coding RNAs could participate in its pathophysiology. The
lncRNAs currently associated with thismental illness are DISC-2,
Gomafu, EVF-2 and BDNF-AS (Table 1). Their degree of
association with schizophrenia varies from direct in cases where
the actual lncRNA is abnormal in patients suffering this psychotic
disorder to indirect in cases where lncRNAs regulate proteins or
mRNAs known to be deficient in schizophrenia. In the following
paragraphs we will discuss each of those lncRNAs with direct, as
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TABLE 1 | Long non-coding RNAs associated with schizophrenia.
LncRNA Type of Brain area
lncRNA
DISC-2 NAT No data currently available
Gomafu ∗ CA1, hindbrain, nucleus acumbens and
temporal gyrus
Evf2 NAT Forebrain, hippocampus and dentate gyrus
BDNF-AS NAT Frontal cortex, infundibulum, corpus mammilare
medulla, pons, cerebellum, hippocampus, amygdala,
globus pallidus, putamen, caudate and thalamus,
∗Gomafu belongs to a novel family of noncoding RNAs refer to text for further
information.
well as indirect, association with schizophrenia. We will specify
the strength of the evidence linking each specific lncRNA with
this psychotic disorder.
DISC-2
In the early 2000s, a balanced translocation (1:11) (q42.1:q14.3)
that segregates with schizophrenia and related disorders was
found in a large Scottish family with a high loading for major
mental illnesses (Millar et al., 2000; Blackwood et al., 2001).
Long-term follow-up of this family has provided information
about 87 family members, of whom 37 carry the translocation.
Twenty nine individuals carrying the translocation, for whom
psychiatric assessment was possible, have psychiatric illnesses,
seven have a diagnosis of schizophrenia, one has bipolar
disorder and 10 subjects present recurrent major depressive
disorder. Thus, 18 of 29 translocation carriers are diagnosed
with major psychiatric disorders whereas none of the 38 non-
translocation carriers have any mental illness (Blackwood et al.,
2001). This translocation affects the Disrupted-in-Schizophrenia
(DISC) locus and results in a defective DISC-1 protein
that lacks a carboxy-terminal (Kamiya et al., 2005; Sachs
et al., 2005). Other association studies have strengthened the
relationship between the DISC locus and schizophrenia. For
instance, several studies support the evidence that variations
at the DISC locus predispose individuals to schizophrenia,
schizoaffective disorder and bipolar illness. In Hodgkinson
et al. (2004) conducted a case-control study of a North
American white population, they analyzed the DISC locus,
describing multiple haplotypes contained within four haplotype
blocks extending between exon 1 and exon 9 that are
associated with schizophrenia, schizoaffective disorder, and
bipolar disorder. Later, in Sachs et al. (2005) sequenced
portions of DISC-1 in 28 unrelated probands with schizophrenia
and six unrelated probands with schizoaffective disorder.
They detected a 4 bp deletion at the extreme 3’ end of
exon 12 in a proband with schizophrenia. The mutation
was also present in a sibling with schizophrenia, a sibling
with schizoaffective disorder, and the unaffected father. These
findings support the possibility that mutations in the DISC-
1 gene can increase the risk for schizophrenia and related
disorders.
Expression of DISC-1 is widespread, developmentally-
regulated, and high in regions of the brain that are implicated
in schizophrenia, most notably the hippocampus (Millar et al.,
2004). In fact, one study, using western blot analysis in
postmortem brain samples, detected one major band of 70–75
kDa, which was increased in the hippocampus of patients with
schizophrenia when compared to controls (Lipska et al., 2006).
As human brain tissue is not easily accessible; lymphoblastoid
cell lines generated directly from patients with this psychotic
disorder have been used to obtain data on gene expression. In cell
lines derived from members of the t(1:11) family, DISC-1 gene
expression was decreased at both the mRNA and protein level
in translocation carriers compared to normal karyotype controls
(Millar et al., 2005).
The role of DISC-1 for proper brain function and
development is not entirely understood, but is thought to
be involved in neuronal migration, synaptogenesis, and
glutamatergic transmission (Miyoshi et al., 2003; Morris et al.,
2003; Ishizuka et al., 2006; Porteous et al., 2006). It was also
recently discovered that DISC-1 can regulate dopamine signaling
by interacting with activating transcription factor 4 (ATF4)
and then repressing phosphodiesterase 4D (PDE4D; Soda et al.,
2013). In addition, several studies have directly related DISC-1
to neurostructural dynamics, as will be presented later in this
manuscript (Miyoshi et al., 2003; Ozeki et al., 2003; Kamiya et al.,
2005).
While significant information is available about DISC-1, less
is known about DISC-2. DISC-2 is located on the opposite
strand to DISC-1 and is transcribed in a distal to proximal
orientation, thus representing a NAT that lacks any significant
coding potential and partially overlaps DISC-1 (Millar et al.,
2000). As a NAT, it is believed to function as a negative
regulator of its protein-coding counterpart, DISC-1 (Millar
et al., 2000; Taylor et al., 2003; Chubb et al., 2008). In
Millar et al. (2000) cloned and sequenced the breakpoints of
the 1:11(q42.1:a14.3) translocation linked to schizophrenia and
identified both genes DISC-1 and DISC-2. They suggested that
DISC-2 presents an attractive mechanism by which DISC-
1 expression may be regulated and proposed that alteration
of DISC-1 and/or DISC-2 activity, by truncation and/or by
abnormal regulation of expression, is causally linked to the
psychiatric illnesses present in translocation carriers. Later, a
systematic review compiling information about the DISC locus
and mental disorders also proposed that disruption of DISC-2
might have a role in the pathophysiology of schizophrenia
through dysregulation of DISC-1 expression (Chubb et al.,
2008).
Although there is no direct evidence linking the DISC-2 gene
to schizophrenia there are strong data supporting an association
between the DISC locus and this mental illness. It must be kept in
mind that most association studies do not discriminate between
DISC-2 and DISC-1 in terms of positive linkage and association
(Chubb et al., 2008); furthermore, many studies report markers
that are within the DISC-2 gene region (Ekelund et al., 2001,
2004; Hodgkinson et al., 2004; Cannon et al., 2005). Perhaps
most importantly, as mentioned above, the DISC-2 gene is
also disrupted by the t(1:11) translocation (Millar et al., 2000).
Consequently, there is no direct evidence yet, linking DISC-2
with schizophrenia, but its role within the DISC locus makes this
association very likely.
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Gomafu
Gomafu—also known as myocardial infarction-associated
transcript (MIAT) was originally identified in 2004. It was
found in a specific set of neurons in the mouse retina and was
described as a noncoding RNA (Blackshaw et al., 2004). In
Sone et al. (2007) established Gomafu as a member of a novel
family of noncoding RNAs that constitutes a cell-type-specific
component of the nuclear matrix. Gomafu is located in a
novel nuclear compartment, which is enriched in pre-mRNA
splicing factors, where it specifically interacts with splicing
factor 1 (SF1; Tsuiji et al., 2011). Indeed, Sone et al. (2007),
coined the name ‘‘Gomafu’’ to reflect the Japanese word for
the speckled pattern in which it is distributed throughout the
nucleoplasm.
Gomafu is widely and abundantly expressed in the nervous
system throughout development and its expression continues
into adulthood (Sone et al., 2007; Tsuiji et al., 2011). In adult
mice, Gomafu is found in CA1 pyramidal neurons of the
hippocampus and large cortical neurons in the hindbrain (Sone
et al., 2007). This family of noncoding RNA participates in
retinal development (Blackshaw et al., 2004; Rapicavoli and
Blackshaw, 2009; Rapicavoli et al., 2010), brain development
(Mercer et al., 2010), and post-mitotic neuronal function (Sone
et al., 2007; Mercer et al., 2008). Gomafu became clinically
relevant, in 2006, when Albertson et al. (2006) found a transcript
assumed to encode a hypothetical protein highly increased
in postmortem brains of human drug abusers. Subsequent
bioinformatic analyses revealed that this transcript did not
encode a protein and, instead, it corresponded to Gomafu
(MIAT) (Ishii et al., 2006). The same team later demonstrated
that Gomafu is upregulated in the nucleus accumbens of human
heroin users and suggested that dysregulation of Gomafu can
influence behavior (Albertson et al., 2006; Michelhaugh et al.,
2011).
Despite Gomafu’s location in a chromosomal region linked
to schizophrenia (22q12.1) (Takahashi et al., 2003), it was not
until 2013 that this long noncoding RNA was associated with
this mental illness. An Australian team found Gomafu to be
downregulated in the cortical gray matter from the superior
temporal gyrus of patients with schizophrenia (Barry et al.,
2014). They also demonstrated that this lncRNA regulates
nuclear splicing factors that ultimately affect schizophrenia
related genes such as DISC-1 and ErbB4 (Barry et al., 2014).
In addition, Gomafu binds to QKI, a protein itself implicated
in schizophrenia (Barry et al., 2014). The QKI gene codes for a
family of alternative spliced gene products (QKI-5 kb, QKI-6 kb,
QKI-7 kb andQKI-7 kb-B) that regulatemyelination by Schwann
cells and oligodendrocytes (McCullumsmith et al., 2007). All
four QKI splicing variants are expressed in the frontal cortex
of human brain and the relative mRNA expression levels of the
QKI splice-variant QKI-7 kb is down-regulated in schizophrenic
patients (Aberg et al., 2006). There are consequently direct and
indirect data associating Gomafu with this psychotic disorder.
Evf2
Evf2 is a NAT of the DLx5/DLx6 gene (Magistri et al., 2012).
Evf2 was discovered in the developing mouse forebrain and it
is transcribed from the ultra-conserved Dlx5/6 region encoding
the homeodomain transcription factors DLx5 and DLx6 (Feng
et al., 2006). Dlx homeobox genes products play a crucial role
in migration and differentiation of the subpallial precursor cells
that give rise to various subtypes of gamma-aminobutiric acid
(GABA)-expressing neurons of the forebrain, including local-
circuit cortical interneurons (Poitras et al., 2010). Interneurons
play a vital role in modulating the activity of the cerebral cortex
and they rely on the enzyme glutamic acid decarboxylase 67
(GAD67) for the synthesis of GABA (Addington et al., 2005),
the major inhibitory neurotransmitter in the brain. In Bond
et al. (2009) demonstrated that Evf2 plays a critical role in
regulating genes involved in the development of interneurons.
This research team showed that loss of Evf2 results in imbalanced
gene expression, leading to decreased GABAergic interneurons
in early postnatal hippocampus and dentate gyrus (Bond et al.,
2009). They also discovered that, in the developing ventral
forebrain, Evf2 recruits Dlx and MECP2 transcription factors to
key DNA regulatory elements in the DLx 5/6 intergenic region to
control DLx5, DLx6 and GAD67 expression (Bond et al., 2009).
There is no direct evidence showing abnormal levels of Evf2
in schizophrenia. However, there are data demonstrating that
GAD67 and DLx1 are defective in these patients and both
GAD67 and DLx1 are directly regulated by Evf2 as mentioned
earlier (Bond et al., 2009). Numerous independent research
teams have found GAD67 expression to be decreased in various
brain regions of patients with schizophrenia (Akbarian et al.,
1995; Guidotti et al., 2000; Woo et al., 2004). Moreover, recently,
Joshi et al. demonstrated for the first time that DLx1 and GAD67
mRNA levels are reduced in the orbitofrontal gray matter of
individuals with this mental illness (Joshi et al., 2012). Thus, there
is an indirect relationship between EVf2 and schizophrenia and
more specifically between Evf2, the development of GABAergic
interneurons, and this psychotic disorder.
BDNF-AS
BDNF antisense (BDNF-AS) has been described as an
endogenous non-coding antisense RNA transcribed from
the human BDNF gene locus (Pruunsild et al., 2007). High
levels of BDNF-AS are present in the brain, kidney, spinal cord
and testis and are generated as a result of alternative splicing
(Pruunsild et al., 2007). Alternatively spliced isoform diversity
is common to many eukaryotic organisms and is widely used in
the nervous system (Lipscombe, 2005). It is important to note
that both BDNF and BDNF-AS share a common sense-antisense
overlapping region (Liu et al., 2006; Pruunsild et al., 2007).
More importantly, it has been demonstrated that this NAT
regulates the expression of BDNFmRNA and protein in vivo and
in vitro (Modarresi et al., 2012). In fact, knockdown of BDNF-AS
increases BDNF mRNA levels and considerably increases the
expression of BDNF protein (Modarresi et al., 2012).
BDNF belongs to a class of secreted growth factors that
are essential for supporting neuronal growth, survival, synaptic
plasticity and it is also involved in learning and memory
neuregulin can elicit neurite outgrowth throughk (Kang and
Schuman, 1995; Figurov et al., 1996; Yamada et al., 2002).
While BDNF-AS has not, to our knowledge, been studied
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in schizophrenia, BDNF gene and protein have been largely
associated with this psychotic disorder (Bellon et al., 2011).
An important reduction of BDNF mRNA was observed in
the prefrontal cortex and the hippocampus of patients with
chronic schizophrenia (Favalli et al., 2012). In addition, a similar
reduction of BDNF mRNA was observed in the dentate gyrus
and hippocampus of affected individuals (Thompson Ray et al.,
2011). Hence, there is only indirect evidence of BDNF-AS
association with schizophrenia, as only BDNF has been studied
in this context.
Long Non-Coding RNAs, Schizophrenia and
Neuronal Structure
It is well established that neurons are structurally plastic
throughout development (Tavosanis, 2012; Urbanska et al.,
2012). But it only recently was demonstrated that neurons retain
a certain degree of structural plasticity in adulthood (Mizrahi
and Katz, 2003; De Paola et al., 2006; Galimberti et al., 2006; Lee
et al., 2006; Nishiyama et al., 2007; Chow et al., 2009; Holtmaat
and Svoboda, 2009; Marik et al., 2010; Chen et al., 2011; Nacher
et al., 2013). Moreover, this plasticity becomes even more evident
during learning (Holtmaat and Svoboda, 2009; Caroni et al.,
2012). The presence of a dynamic neuronal structure throughout
life could help reconcile a number of apparent unrelated findings
in schizophrenia as will be presented later in this manuscript.
One of the factors to be established is which molecules regulate
these dynamic changes in neuronal shape. LncRNAs represent
promising candidates as they are prominent regulators of gene
expression and they are highly active during brain development.
As a first step in associating lncRNAs with variations in neuronal
architecture, here we review if those genes regulated by lncRNAs
linked to schizophrenia can alter neuronal structure.
DISC-1 has been consistently associated with neurostructural
dynamics (Miyoshi et al., 2003; Ozeki et al., 2003; Kamiya et al.,
2005). It has been shown that transfection of mutant DISC-1
into PC12 cells results in shorter neurites (Ozeki et al., 2003),
while decreasing the expression of DISC-1 by RNA interference,
inhibits neurite outgrowth in the same type of cells (Kamiya
et al., 2005). Furthermore, in utero gene-transfer techniques in
rodents have shown that DISC-1 loss induces shorter dendrites
that are randomly oriented in the cerebral cortex (Ozeki et al.,
2003). The mechanism of action for DISC-1 as a transformer
of neuronal structure remains a work in progress. What is
currently known is that DISC-1 interacts with FEZ-1 to promote
cytoskeletal dynamics that lead to the extension of neuronal
processes (Bloom and Horvitz, 1997; Kuroda et al., 1999). As
we previously mentioned, it seems likely that DISC-2 regulates
the expression of DISC-1 (Figure 1) at the DISC locus (Millar
et al., 2000; Chubb et al., 2008). The fact that DISC-1 and its
antisense partner DISC-2 overlap in a specific gene region and
that both molecules are extensively expressed in the brain (Millar
et al., 2000) during complex developmental processes and also
throughout higher level cognitive tasks, suggests that there is at
least some degree of interaction between DISC-1 and DISC-2
(Chubb et al., 2008).
Gomafu was recently implicated as another lncRNA
involved in regulating the expression of DISC-1 and ErbB4.
Overexpression of Gomafu in stem cells significantly decreases
the expression of both DISC-1 and ErbB4 and their alternatively
spliced variants (Barry, 2014). Conversely, knocking down
Gomafu increases the expression of both DISC-1 and ErbB4
splice variants, but not their predominant, mature transcripts
(Barry, 2014). Interestingly, these results almost exactly match
the aberrant splicing pattern seen in post-mortem studies of
patients with schizophrenia (Law et al., 2007; Nakata et al.,
2009). Therefore, DISC-1 effects on neuronal structure could be
regulated by either Gomafu or DISC-2.
As mentioned above, Gomafu also regulates the expression
of ErbB4, a protein that has been associated with schizophrenia.
Postmortem studies in patients with this mental illness showed
altered levels of neuregulin-1 (NRG1) and its receptor, ErbB4,
in prefrontal cortex (Chong et al., 2008). ErbB4 activation
by neuregulin can elicit neurite outgrowth through two
different enzymes—kinase (MAPK) and protein kinase C (PKC;
Vaskovsky et al., 2000). The down-stream cascade of MAPK
and PKC appears to be activation of Cdc42 which leads to
fillopodium formation (Shigeta et al., 2003). Activation of
Rac, also mediated by PKC, results in actin polymerization
that leads to the formation of lamellipodium (Pilpel and
Segal, 2004). Both fillopodium and lamellipodium are actin
structures that participate in neurostructural rearrangements
(Bellon, 2007). Another example of the role of ErbB4 in
structural plasticity comes from a study published in 2008
that demonstrated that depletion of ErbB4 decreases the
number of primary neurites in hippocampal cultures, whereas
stimulation of ErbB4 using a soluble form of NRG1 results
in increased dendritic arborizations via activation of the
tyrosine kinase domain of ErbB4 and the phosphoinositide
3-kinase pathway (Krivosheya et al., 2008). Hence, there is
clear evidence indicating that Gomafu regulates two proteins
capable of transforming neuronal structure namely DISC-1 and
ErbB4.
Another lncRNA, Evf2, affects neuronal shape through its
association with Dlx genes and by regulating the expression of
GAD67. In Plavicki et al. (2012) characterized the distal-less (dll)
gene in the invertebrate nervous system; they used this single
invertebrate gene as a homolog of the Dlx genes in vertebrates,
proposing that the existence of a single dll gene in Drosophila
has the potential to provide insight into how disruptions of Dlx
function result in aberrant neuronal development in vertebrates.
Altering the expression of the Dlx homolog, distal-less, disrupts
normal dendrite and axon development in the olfactory system
(Plavicki et al., 2012). The authors suggest that dll could serve
as a pathfinding molecule in this brain area (Plavicki et al.,
2012). Similar results are observed in rodents. Mice with a null
allele of the Dlx5 gene do not form axons that would normally
connect the olfactory epithelium with the olfactory bulb (Long
et al., 2003). This lack of axonal extension appears to be due
to the absence of Dlx5 chemoattractant effects (Levi et al.,
2003).
The influence of GAD67 on neuronal structure is of a different
nature. If the enzymatic activity of GAD67 is diminished during
development, either by pharmacological or genetic means, then
pruning of synapses decreases (Nakayama et al., 2012). This
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FIGURE 1 | Long non-coding RNAs (ncRNAs) associated with schizophrenia and its effects in the neuronal structure. Most lncRNAs associated with
schizophrenia are natural antisense transcripts (NATs; i.e., DISC-2, Evf2 and BDNF-AS). This figure illustrates in the upper left corner (A) a NAT (green arrow) being
transcribed and consequently stopping transcription for genes that would have been transcribed in the normal transcription sense (red arrow). (B) In some instances
transcription of NATs prevents the formation of mRNAs and (C) further translation of these mRNAs into proteins such as DISC-1 and BDNF. On the lower left corner
(D) a diagram exemplifies how proteins such as BDNF can activate membrane receptors and then elicit dynamic structural changes in neurons.
means that elimination of the GABA synthesizing enzyme
GAD67 results in more prominent arborizations. Therefore, by
controlling the expression of Dlx genes as well as the enzyme
GAD67, Evf2 can transform neuronal structure.
Finally, it is widely accepted that BDNF promotes
neurostructural dynamics during development and adult
life (Bellon et al., 2011). For instance, mutant juvenile mice
in which BDNF levels are modestly increased display higher
numbers of first-order dendrites, total dendritic length, and
total branch points in dentate gyrus granule cells (Tolwani
et al., 2002; Bellon et al., 2011). Similarly, the introduction
of BDNF to hippocampal slices elicits an increase in the
number of spines and augments apical dendritic length in
pyramidal cells (Alonso et al., 2004; Bellon et al., 2011).
Also, BDNF triggers dendritic spine maturation during the
transition between adolescence to adulthood (An et al.,
2008). Most important to our current topic is a recent
association between BDNF, BDNF-AS and changes in neuronal
structure. In 2012, it was found that increasing endogenous
BDNF by knocking down BDNF-AS transcript results in
neurite outgrowth and maturation in human and mouse
cell lines (Modarresi et al., 2012). This information directly
associates BDNF-AS with modifications in neuronal architecture
(Figure 1).
In summary, there are data suggesting lncRNAs, associated
with schizophrenia, regulate proteins that can transform
neuronal shape (Figure 1). For some, such as BDNF-AS, the
evidence is strong while for others, such as Gomafu and Evf2, the
evidence is indirect, and the data currently available on DISC-2
remain weak.
Discussion
After 50 years of intense research, it is now clear that a
single gene or protein cannot explain such a complex illness
as schizophrenia. We currently know that there are numerous
genes, proteins, mRNAs, miRNAs and lncRNAs that have been
associated with this mental disorder. The growing variety of
molecules associated with schizophrenia could involve numerous
cellular mechanisms including: cell migration, cell survival,
neurogenesis, andmany others. Consequently, one of the current
challenges is to establish if there is a single cellular process
that can consolidate all these molecules (and their functions)
and, at the same time, explain the most consistent findings in
schizophrenia.
We propose that a core deficit in schizophrenia is the
establishment and maintenance of neuronal structure as it is
now evident that the old dogma of a structural static brain
is no longer valid. Recent in vivo evidence, using two-photon
microscopy, has demonstrated that neurons remain structurally
plastic throughout life (De Paola et al., 2006; Galimberti
et al., 2006; Lee et al., 2006; Nishiyama et al., 2007; Chow
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et al., 2009; Holtmaat and Svoboda, 2009; Marik et al., 2010;
Chen et al., 2011; Nacher et al., 2013) and not only during
development as was originally thought. This structural plasticity
involves, in addition to constant turnover of dendritic spines
and axonal boutons (Holtmaat and Svoboda, 2009; Caroni
et al., 2012), extension and retraction of dendritic and axonal
shafts (De Paola et al., 2006; Galimberti et al., 2006; Lee
et al., 2006; Nishiyama et al., 2007; Chow et al., 2009; Marik
et al., 2010; Chen et al., 2011). Transformations in neuronal
shape occur even when brain activity is at baseline without
any particular environmental stimuli (De Paola et al., 2006;
Galimberti et al., 2006; Lee et al., 2006; Nishiyama et al., 2007;
Chow et al., 2009; Marik et al., 2010; Chen et al., 2011) and
becomes more prominent during complex cognitive tasks such
as learning (Holtmaat and Svoboda, 2009; Caroni et al., 2012).
The relevance of these dynamic changes to the physiology
of the brain is also apparent under stressful circumstances.
Chronic stress elicits dendritic atrophy in the prefrontal cortex
and hippocampus, whereas it promotes dendritic growth in
the amygdala (Radley and Morrison, 2005). If the stressful
event is removed, atrophic dendrites re-establish their original
structure (Radley et al., 2005), which clearly illustrates how
structurally plastic neurons can be. Structural plasticity is not
limited to neurons. Astrocytes, after only minutes of brain
stimulation, can extend processes in order to regulate synaptic
transmission (Perez-Alvarez et al., 2014) and to promote
excitatory synapse stability (Bernardinelli et al., 2014). Therefore,
it is now obvious that continuous structural changes are part
of normal brain functioning during development, as well as in
adult life.
If schizophrenia is framed within the context of an ever
changing neuronal shape, a number of apparent unrelated
and inconsistent findings could be theoretically reconciled.
For instance, it is widely accepted that schizophrenia is
a developmental disorder in which exposure to famine or
infection during pregnancy increases the risk for acquiring
this mental disorder (MacDonald and Schulz, 2009). It has
also been recognized that migrants to northern latitudes
are at higher risk for developing this illness (MacDonald
and Schulz, 2009). Similarly, lifetime cannabis use augments
the probability of developing schizophrenia (MacDonald and
Schulz, 2009). While these findings appear to be unrelated, all
these risks factors may ultimately impact neuronal structure.
Postmortem reports of malnourished infants have evidenced
shorter and less ramified dendrites (Cordero et al., 1993;
Benitez-Bribiesca et al., 1999). Similar structural deficits
are observed in offspring when pregnant rodents undergo
viral infection and these deficits persist even when the
offspring have reached adulthood (Fatemi et al., 2002).
Migration to northern latitudes is associated with vitamin
D deficiency (Dealberto, 2013) and this vitamin maintains
proteins directly involved in neurostructural dynamics (Féron
et al., 2005). In fact, vitamin D can directly elicit growth
of neuronal extensions in hippocampal neurons (Brown
et al., 2003). Similarly, chronic cannabis exposure leads to
altered dendritic structure in rats (Lawston et al., 2000).
Unfortunately, data linking neuronal structure with all these
risk factors for schizophrenia directly in patients’ cells is still
lacking.
There is also information about the schizophrenia course
and its clinical picture that could be explained by a defect
in neurostructural dynamics. Neuroimaging studies strongly
suggest that overt psychosis becomes evident while the
last major pruning of brain connections is taking place
(Thompson et al., 2001; Vidal et al., 2006; Sun et al., 2009a,b).
This pruning normally occurs in late adolescence and early
adulthood (Huttenlocher, 1990; Giedd et al., 1999; Gogtay
et al., 2004; Lenroot and Giedd, 2006) when schizophrenia
is most commonly diagnosed. It is possible that the removal
of more connections in schizophrenia is a consequence of
malformed dendrites and axons. But within this framework,
how can we explain prodromal symptoms? There is no clear
explanation for the origin of these symptoms; however, it
is well recognized that during brain development and until
adolescence the brain generates more connections than needed
and only through different pruning episodes is the proper
connectivity pattern finally acquired. This over-connectivity
present until adolescence seems to protect patients from overt
psychosis, but not from motor coordination anomalies, social
difficulties and cognitive deficits (Marenco and Weinberger,
2000). These symptoms could result from neurons’ inability
to constantly adjust their structure in response to external
stimuli. Studies in rodents have demonstrated that learning
involves drastic transformations in neuronal shape (Holtmaat
and Svoboda, 2009; Caroni et al., 2012) while, in humans,
different neuroimaging techniques have shown structural brain
modifications after learning and training (Draganski et al.,
2004, 2006; Sagi et al., 2012). One of the most consistent
prodromal symptoms in schizophrenia is cognitive difficulties
(Marenco and Weinberger, 2000). Consequently, a deficit in
neurostructural dynamics could in theory explain the cognitive
symptoms present not only during the prodromal phase but also
throughout the illness course. Yet, there is still no information
about brain structural deficits during learning in patients with
schizophrenia.
The most consistent finding in schizophrenia, namely
decreased brain volume and enlarged ventricles (Van Horn
and McManus, 1992; Gur et al., 1994; Wright et al., 2000;
Woods et al., 2005) can also stem from a deficit in neuronal
structure. Postmortem studies have shown shorter and less
ramified neuronal extensions in numerous brain areas including
prefrontal cortex (Benes et al., 1986, 1991; Selemon et al., 1995,
1998; Kalus et al., 2000, 2002; Pierri et al., 2001, 2003; Broadbelt
et al., 2002; Black et al., 2004), occipital cortex (Selemon et al.,
1995), motor cortex (Benes et al., 1986), anterior cingulate
cortex (Benes et al., 1986; Kalus et al., 2000, 2002; Chana
et al., 2003), auditory cortex (Sweet et al., 2009), entorhinal
cortex (Arnold et al., 1995), insular cortex (Pennington et al.,
2008), subiculum (Arnold et al., 1995; Rosoklija et al., 2000),
hippocampal subfields CA1, 2, 3 and 4 (Benes et al., 1991;
Arnold et al., 1995; Zaidel et al., 1997; Jonsson et al., 1999;
Kolomeets et al., 2005), cerebellar vermis (Tran et al., 1998),
mediodorsal thalamus (Byne et al., 2002) and pulvinar (Byne
et al., 2002). Even glial cells and neuronal-like cells derived
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from induced pluripotent stem cells have shown abnormal
arborizations (Rajkowska et al., 2002). This broad range of
affected brain regions strongly suggests that the entire brain is
compromised.
The clinical picture of patients with schizophrenia supports
this hypothesis of generalized brain dysfunction. Schizophrenia
is commonly associated with psychotic symptoms; however,
patients also experience negative symptoms such as lack of
motivation and alogia, as well as cognitive difficulties such
as attention problems and memory deficits. Less recognized,
but also well documented in the scientific literature, are soft
neurologic signs (Hui et al., 2009), oculomotor anomalies
(Picard et al., 2008), disequilibrium (Picard et al., 2008),
olfactory impediments (Turetsky et al., 2009) and the
spontaneous appearance of abnormal movements even in
the absence of antipsychotics (Walther and Strik, 2012). This
wide variety of signs and symptoms is unlikely to originate
from a single brain region or even from an isolated circuit.
Instead, it could be explained by a generalized defect in
neuronal structure. Within this framework, brain areas that
contain neurons with more complex arborizations such as
the hippocampus and the prefrontal cortex would be more
affected, whereas brain regions carrying neurons with simple
branches, like the olfactory bulb, would be less impaired. This
proposition is consistent with the fact that the hippocampus
and the prefrontal cortex are commonly associated with
schizophrenia.
Based on this information, we believe there are a number
of research lines suggesting a potential association between
defective neurostructural dynamics and schizophrenia. One
essential aspect is establishing which molecules regulate
these constant changes in neuronal shape and lncRNAs are
promising candidates. First, because the group of lncRNAs
associated with schizophrenia is highly active during
development when neuronal structure is more plastic and
it is also during this life stage when schizophrenia seems
to originate (Marenco and Weinberger, 2000; Rapoport
et al., 2005). In addition, there is information that at least
Gomafu remains active during adulthood (Albertson et al.,
2006). Gomafu’s pattern of activity correlates with what is
currently known about neuronal structural plasticity which
is robust during development and then less active during
adulthood.
A second important factor that suggests a potential
association between lncRNAs, neurostructural dynamics
and schizophrenia is that either lncRNAs (Table 1), or
the genes they regulate, are active in numerous brain
regions including: prefrontal cortex (Favalli et al., 2012),
temporal gyrus (Barry et al., 2014) hippocampus, dentate
gyrus (Bond et al., 2009; Thompson Ray et al., 2011; Favalli
et al., 2012), nucleus accumbens (Albertson et al., 2006;
Michelhaugh et al., 2011) and olfactory bulb (Long et al.,
2003). This lncRNA’s capacity to act in several brain areas
is in line with the clinical picture of schizophrenia and with
anatomopathological results indicating there is broad brain
involvement in this mental illness as was presented earlier in the
discussion.
In addition, emerging information links known risk factors
for schizophrenia such as malnutrition, infection during
pregnancy and vitamin D deficiency with lncRNAs. For instance,
the lncRNA growth arrest-specific 5 (Gas5) is implicated in
certain metabolic pathways during starvation (Kino et al., 2010;
Osborne-Majnik et al., 2013). It was also recently discovered that
lncRNAs regulating responses to infections during pregnancy
are involved with obstetric complications (Wang et al., 2014).
Moreover, just last year it was revealed that vitamin D signaling
can regulate the expression of certain lncRNAs (Jiang and
Bikle, 2014). However, the role of these particular lncRNAs
in the pathophysiology of schizophrenia needs to be further
studied.
The strongest indication yet available about the possibility
of lncRNAs controlling neurostructural dynamics and their
potential involvement with schizophrenia comes from BDNF-
AS and Gomafu. Data coming directly from patients have
consistently associated BDNF with schizophrenia (Bellon et al.,
2011; Thompson Ray et al., 2011; Favalli et al., 2012), while
in vitro studies have shown that increasing endogenous BDNF by
knocking down BDNF-AS transcript results in neurostructural
rearrangements (Modarresi et al., 2012). But BDNF-AS has not
been directly associated with schizophrenia and consequently
its plausible role as a regulator of neurostructural dynamics
in this mental illness has yet to be determined. In contrast,
Gomafu has been directly linked with schizophrenia. This
lncRNA is downregulated in the cortical gray matter of patients
with this psychotic disorder (Barry et al., 2014). Moreover,
Gomafu regulates genes also associated with schizophrenia
(Barry et al., 2014) such as DISC-1 (Millar et al., 2000,
2005; Blackwood et al., 2001; Hodgkinson et al., 2004; Sachs
et al., 2005; Lipska et al., 2006) and ErbB4 (Chong et al.,
2008; Barry et al., 2014) and these genes have been shown
to be directly involved in neurostructural dynamics (Bloom
and Horvitz, 1997; Kuroda et al., 1999; Vaskovsky et al.,
2000; Miyoshi et al., 2003; Ozeki et al., 2003; Kamiya
et al., 2005; Krivosheya et al., 2008). Nonetheless, a direct
deficit in neurostructural dynamics caused by either Gomafu,
DISC-1 or ErbB4 in patients with schizophrenia has not been
established.
In conclusion, there could be an association between
schizophrenia, lncRNAs and neurostructural dynamics, but
direct evidence is lacking. However, research on lncRNAs is
rapidly evolving. There is tantalizing evidence that lncRNAs
could help clarify the still enigmatic genetic contribution to
schizophrenia. This could be particularly true if schizophrenia
is approached within the context of dynamic changes in
neuronal structure that start during development and continue
throughout life.
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